Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 1 of 4,039
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AS 101 |
n/a |
10 mg |
2446/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 101 |
n/a |
50 mg |
2446/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 101 |
n/a |
10 mg |
3367/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 101 |
n/a |
50 mg |
3367/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 101 |
Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1alpha, IL-2 and TNF-alpha release. Minimum Purity: > 98% |
50mg |
2446 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 101 |
Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1alpha, IL-2 and TNF-alpha release. Minimum Purity: > 98% |
10mg |
2446 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 101 |
R-(-)-enantiomer of gossypol (Cat. No. 1964). Mimics the BH3 domains of Bcl-2, Bcl-XL and Mcl-1. Disrupts heterodimerization of Bcl-2 with proapoptotic family members. Induces apoptosis in vitro through activation of caspase-9; cytotoxic to multip... |
10mg |
3367 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 101 |
R-(-)-enantiomer of gossypol (Cat. No. 1964). Mimics the BH3 domains of Bcl-2, Bcl-XL and Mcl-1. Disrupts heterodimerization of Bcl-2 with proapoptotic family members. Induces apoptosis in vitro through activation of caspase-9; cytotoxic to multip... |
50mg |
3367 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 1120 |
n/a |
10 mg |
3793/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 1120 |
n/a |
50 mg |
3793/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 1120 |
High affinity retinol-binding protein 4 (RBP4) ligand (Ki = 8.3 nM); non-retinoid. Selective against a range of different cellular targets. As efficacious as fenretinide (Cat. No. 1396) in the reduction of serum RBP4 and retinol. Displaces transth... |
50mg |
3793 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 1120 |
High affinity retinol-binding protein 4 (RBP4) ligand (Ki = 8.3 nM); non-retinoid. Selective against a range of different cellular targets. As efficacious as fenretinide (Cat. No. 1396) in the reduction of serum RBP4 and retinol. Displaces transth... |
10mg |
3793 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1269574 |
GPR119 Receptor Agonist |
10 mg |
4177/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1269574 |
GPR119 Receptor Agonist |
50 mg |
4177/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1269574 |
GPR119 receptor agonist (EC50 = 2.5 µM in HEK293 cells expressing human GPR119). Enhances insulin secretion stimulated by glucose in vivo. Orally available. Minimum Purity: > 98% |
10mg |
4177 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1269574 |
GPR119 receptor agonist (EC50 = 2.5 µM in HEK293 cells expressing human GPR119). Enhances insulin secretion stimulated by glucose in vivo. Orally available. Minimum Purity: > 98% |
50mg |
4177 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 18986 |
Positive allosteric modulator of AMPA receptors. Exhibits cognitive enhancing properties in rodent behavioral models. Brain penetrant. Minimum Purity: > 98% |
10mg |
3911 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 18986 |
Positive allosteric modulator of AMPA receptors. Exhibits cognitive enhancing properties in rodent behavioral models. Brain penetrant. Minimum Purity: > 98% |
50mg |
3911 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 19 |
5-HT7 Receptor Agonist |
10 mg |
1968/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 19 |
5-HT7 Receptor Agonist |
50 mg |
1968/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 19 |
Potent 5-HT7 receptor agonist (IC50 = 0.83 nM). Enhances memory consolidation and reverses scopolamine- or dizocilpine-induced amnesia in vivo. Minimum Purity: > 98% |
10mg |
1968 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 19 |
Potent 5-HT7 receptor agonist (IC50 = 0.83 nM). Enhances memory consolidation and reverses scopolamine- or dizocilpine-induced amnesia in vivo. Minimum Purity: > 98% |
50mg |
1968 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1949490 |
Inositol Phosphatase Inhibitor |
10 mg |
3718/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1949490 |
Inositol Phosphatase Inhibitor |
50 mg |
3718/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1949490 |
Selective SHIP2 (SH2 domain-containing inositol 5'-phosphatase 2) inhibitor (IC50 values are 0.34 µM and 0.62 µM for mouse and human respectively); displays approximately 30-fold affinity for SHIP2 over SHIP1. Increases insulin-induced... |
10mg |
3718 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1949490 |
Selective SHIP2 (SH2 domain-containing inositol 5'-phosphatase 2) inhibitor (IC50 values are 0.34 µM and 0.62 µM for mouse and human respectively); displays approximately 30-fold affinity for SHIP2 over SHIP1. Increases insulin-induced... |
50mg |
3718 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 205804 |
Cell Adhesion Inhibitor |
10 mg |
2524/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 205804 |
Cell Adhesion Inhibitor |
50 mg |
2524/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 205804 |
Selective inhibitor of E-selectin and ICAM-1 expression (IC50 values are 20, 25 and > 1000 nM for TNF-alpha-induced E-selectin, ICAM-1 and VCAM-1 expression respectively). Effective inhibitor of cell-cell adhesion in an in vitro flow experiment. M... |
10mg |
2524 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 205804 |
Selective inhibitor of E-selectin and ICAM-1 expression (IC50 values are 20, 25 and > 1000 nM for TNF-alpha-induced E-selectin, ICAM-1 and VCAM-1 expression respectively). Effective inhibitor of cell-cell adhesion in an in vitro flow experiment. M... |
50mg |
2524 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 24795 |
Nicotinic (a7) Receptor Agonist |
10 mg |
3518/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 24795 |
Nicotinic (a7) Receptor Agonist |
50 mg |
3518/50 |
 R&D SYSTEMS, INC. |
More Info
|
| S 24795 |
Partial agonist of alpha7 nAChR. Improves mnemonic function in aged mice for the treatment of aging-related memory disturbances. Displays more efficient memory-enhancing effects than memantine (Cat.No 0773) in Alzheimer's disease mouse models. Min... |
10mg |
3518 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 24795 |
Partial agonist of alpha7 nAChR. Improves mnemonic function in aged mice for the treatment of aging-related memory disturbances. Displays more efficient memory-enhancing effects than memantine (Cat.No 0773) in Alzheimer's disease mouse models. Min... |
50mg |
3518 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 252424 |
PI 3-Kinase Inhibitor |
10 mg |
3671/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 252424 |
Potent and selective inhibitor of PI 3-kinase gamma (IC50 values are 33 and 935 nM for PI3Kgamma and PI3Kalpha respectively). Minimum Purity: > 98% |
10mg |
3671 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 25585 |
NPY Receptor Antagonist |
10 mg |
3432/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 25585 |
NPY Receptor Antagonist |
50 mg |
3432/50 |
 R&D SYSTEMS, INC. |
More Info
|
| S 25585 |
Potent neuropeptide Y (NPY) Y5 receptor antagonist (IC50 values are 5.4, > 1000, > 10 000 and > 10 000 nM at Y5, Y1, Y2 and Y4 receptors respectively) that displays no affinity for a wide range of other receptors. Does not produce a conditioned ta... |
10mg |
3432 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 25585 |
Potent neuropeptide Y (NPY) Y5 receptor antagonist (IC50 values are 5.4, > 1000, > 10 000 and > 10 000 nM at Y5, Y1, Y2 and Y4 receptors respectively) that displays no affinity for a wide range of other receptors. Does not produce a conditioned ta... |
50mg |
3432 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 286982 |
Integrin Receptor Inhibitor |
10 mg |
4228/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 286982 |
Integrin Receptor Inhibitor |
50 mg |
4228/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 286982 |
Potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 values are 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays respectively). Minimum Purity: > 99% |
10mg |
4228 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 286982 |
Potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 values are 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays respectively). Minimum Purity: > 99% |
50mg |
4228 |
 TOCRIS BIOSCIENCE |
More Info
|
| 293 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| 293 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| S 32826 |
Autotaxin Inhibitor |
10 mg |
3404/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 32826 |
Inhibitor of autotaxin (IC50 = 9 nM). Displays similar inhibitory effects at all three autotaxin isoforms (alpha, beta and gamma). Exhibits no affinity for lysophosphatidic acid receptor 1 (LPA1) at concentrations up to 10 µM. Inhibits LPA r... |
10mg |
3404 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 56 |
Synthase/Synthetase Inhibitor |
10 mg |
3531/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 56 |
Synthase/Synthetase Inhibitor |
50 mg |
3531/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 56 |
Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. Minimum Purity: > 99% |
10mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 56 |
Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. Minimum Purity: > 99% |
50mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 582941 |
Selective alpha7 nAChR partial agonist; exhibits high affinity for both rat and human alpha7 receptors (Ki values are 10.8 and 16.7 nM respectively). Displays ~15-fold selectivity for alpha7 over 5-HT3 receptors (Ki = 150 nM for 5-HT3). Minimum Pu... |
10mg |
4341 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 582941 |
Selective alpha7 nAChR partial agonist; exhibits high affinity for both rat and human alpha7 receptors (Ki values are 10.8 and 16.7 nM respectively). Displays ~15-fold selectivity for alpha7 over 5-HT3 receptors (Ki = 150 nM for 5-HT3). Minimum Pu... |
50mg |
4341 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
10 mg |
3578/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
50 mg |
3578/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 605240 |
Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammation and damage in both ly... |
10mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammation and damage in both ly... |
50mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
10 mg |
3701/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
50 mg |
3701/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 µM. Reduces nocicep... |
10mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 µM. Reduces nocicep... |
50mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
AMPK Activator |
10 mg |
3336/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
AMPK Activator |
50 mg |
3336/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreases plasma glucose and t... |
10mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreases plasma glucose and t... |
50mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
n/a |
10 mg |
2976/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
n/a |
50 mg |
2976/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and KCNQ2/3 channels. Anti... |
10mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and KCNQ2/3 channels. Anti... |
50mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
10 mg |
2341/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
50 mg |
2341/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
A selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-beta-induced epithe... |
1 mg |
1725-1 |
 BIOVISION, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
10 mg |
2939/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
50 mg |
2939/50 |
 R&D SYSTEMS, INC. |
More Info
|
Search Non-Antibody Products
|